Sage Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Pipeline and Business Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. APGE
5. USO
6. GOOGL
7. MU
8. HOOD
9. DFTX
10. RGNX

Go back to Sage Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Pipeline and Business Progress

SAGE Therapeutics (SAGE) Reports In-Line Q2 EPS

August 2, 2022 6:34 AM EDT

SAGE Therapeutics (NASDAQ: SAGE) reported Q2 EPS of ($2.13), in-line with the analyst estimate of ($2.13). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $1.78 million.

For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.

... More